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Abstract
The ovulatory process has been compared with inflammation. We investigated the state of female peripheral polymorphonuclear
leukocytes (PMN) during menstrual cycles, and found that PMN contained high levels of superoxide, hydrogen peroxide and nitric
oxide (NO) during at the peri-ovulatory period. Assuming the cause of this elevation to be a luteinizing hormone (LH), the surge of
which preceded the ovulation, we examined the responsiveness of PMN to pituitary LH. The results revealed that this hormone
elevated dose-dependently the production of reactive oxygen intermediates (ROI). Furthermore, we demonstrated the mRNA
expression of LH receptors and their presence on PMN. The data indicated that the LH surge before on the ovulatory day resulted
in general activation of PMN, suggesting that this state of PMN may be a necessary step for initiation of ovulation, rather than a
defensive role against infection. # 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
It is generally believed that polymorphonuclear leu-
kocyte (PMN) is the first line of defense against
bacterial infections. During the course of evaluating
reactive oxygen intermediates (ROI) production by
peripheral blood resident PMN of healthy volunteers,
we found female values (0.000/4.942 nmole/2/106
PMN) more deviated than males (0.000/0.555 nmole/
2/106 PMN). Considering this, we tried to elucidate
the possibility that ovulation may influence ROI pro-
duction of PMN, because there were many reports to
suggest that the ovulatory process in the ovary re-
sembled an inflammatory reaction (Espey, 1980; Take-
hara et al., 1994).
These hypotheses depend on the observation of
infiltration of leukocytes in the ovary and the produc-
tion of inflammatory mediators such as TNF-a and IL-
1b apparently also participating in this process (Brann-
strom et al., 1993a,b; Hurwitz et al., 1991; Takehara et
al., 1994). At the peri-ovulatory period rat leukocytes
were reported to be localized in the ovaries (Brannstrom
et al., 1993a,b), and leukocyte supplementation in-
creased the LH-induced ovulation rate in the in vitro-
perfused rat ovary (Hellberg et al., 1991). Furthermore,
administration of a neutrophil-depleting monoclonal
antibody reduced the ovulation rate in the rat (Brann-
strom et al., 1995). Therefore, leukocytes may play an
important role in ovulation. In addition, Polan et al.
reported that ovarian steroids modulated the mRNA
production of TNF-a and IL-1b on cultured peripheral
monocytes (Loy et al., 1992; Polan et al., 1989, 1990).
However, as the release of many kinds of hormones and
cytokines may concomitantly be involved in ovulation
(Hellberg et al., 1991), it may induce general phenomena
rather than a localized reaction to the ovary, although
ovulation does neither accompany a fever, nor leukocy-
tosis. Conversely, the state of peripheral PMN at the
peri-ovulatory period could influence the ovary. There-
fore, we analyzed the states of peripheral blood PMN at
the period during a menstrual cycle.* Corresponding author. Tel./fax: /81-6-6879-2552
E-mail address: dohi@sahs.med.osaka-u.ac.jp (Y. Dohi).
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It was reported that ovulation occurred at the 34/38
h following the plasma onset of the luteinizing hormone
(LH) surge (Andersen et al., 1995; Testart and Frydman,
1982; Testart et al., 1981), which consequently triggered
ovulation (Cunnigham et al., 1997). Therefore, it is
worth examining whether the LH molecules would also
influence PMN at non-ovulatory periods. The degrees of
activation of LH-primed PMN could be evaluated by
comparing those of anti-FcgR (CD16) antibody-primed
PMN, the incubation of which should result in general
activation of PMN.
Receptors for LH (LHR) have been reported to be
expressed on various organs and tissues (Dufau, 1998).
However, its expression on PMN is unknown. Thus, we
have tried to ascertain the mRNA expression of LHR
on PMN by RT-PCR. Furthermore, expression of LHR
on the surface of PMN was examined by the specific
binding of 125I-labeled LH to PMN.
It is well-known that triggering of FcgR of PMN
induces ROI production and kills phagocytized bacteria,
but it is quite unclear what triggering of LHR on PMN
induces. Roles of PMN that have been activated
through LHR on the ovulatory day were discussed.
2. Materials and methods
2.1. Subjects
Twenty non-pregnant, non-infected (that is, no fever,
no leukocytosis, no leukopenia and no recent anamnesis
of infection) women (age 21/37 year average 25.99/
5.61) were subjected to this examination. The average
menstrual cycle was 29.19/2.69 days and the duration of
menstruation was 5/8 days. Informed consent was
provided by all subjects.
2.2. Hormones, chemicals and antibodies
Human pituitary LH, human chorionic gonadotropin
(hCG), follicle-stimulating hormone (FSH) and scopo-
letin were purchased from Sigma Chemical Co., St.
Louis, MO. Luminol, horseradish peroxidase (HPO),
bovine erythrocyte-Cu, Zn-containing superoxide dis-
mutase (SOD) and carboxy-2-phenyl-4,4,5,5-tetra-meth-
yl-imidazoline-1-oxyl-3-oxide (carboxy-PTIO) were
purchased from Wako Chemical Industry, Tokyo,
Japan. Dextran T500, Percoll and Gene imagesTM
were purchased from Amarsham Pharmacia Biotech
AB, Uppsala, Sweden. Hanks balanced salt solution
without phenol red was purchased from GIOBCO BRL,
Life Sciences, Gaithersgurg, MD. SV Total RNA
Isolation System was purchased from Promega Corp.,
Madison, WI. Premix Taq was purchased from Takara
Shuzo Co., Ltd., Otsu, Japan. THERMOSCRIPTTM
RT-PCR System was purchased from Life Technologies,
GIBCO BRL, Glasgow, Scotland, UK. Human ovary
cDNA purchased from Clontech, Palo Alto, CA. Hu-
man LH/hCG receptor cDNA was a generous gift from
Dr Takashi Minegishi at Gunma University, Maebashi,
Japan (Minegishi et al., 1990). Iodine-125 Radionuclide
(NEZ-033H) was purchased from NENTM Life Science
Products, Inc. Boston, MA. Anti-FcgR (CD16, IgG1k,
Clone 3G8), anti-CR1 (CD35, IgG1k, Clone E11), and
anti-CR3 (CD11b, IgG1k, Clone BEAR1) mAbs were
purchased from Pharmingen, San Diego, CA.
2.3. Determination of ovulatory period
Ovulatory period of young women was predicted by
following these three procedures: (1) Survey on basal
body temperature. (2) Check for urine LH concentration
by ‘L-check’ plates (Nipro, Tokyo, Japan) to be a higher
value than 40 IU/l that would expect ovulation within 48
h. (3) Ultrasonographic observation of disappearance of
a large dominant follicle from the ovary. Ovulation was
determined principally by all three procedures per one
subject.
2.4. Purification of peripheral blood polymorphonuclear
leukocytes
Heparinized blood was subjected in 5% Dextran T500
sedimentation, and its supernatant fraction was layered
on top of the discontinuous gradients (75, 70 and 60%)
of Percoll, and then centrifuged for 15 min at 800/g .
The cells from the layer of PMN were collected. This
fraction contained about 98% of neutrophils, 2% of
other types of granulocytes and none of lymphocytes, as
judged under a microscope after Giemsa staining. In all
experiments, leukocytes were counted in Turk’s reagent.
2.5. Determination of superoxide, hydrogen peroxide and
nitric oxide content of PMN
The resident (untreated) and/or stimulated states of
PMN were examined for superoxide, hydrogen peroxide
and nitric oxide (NO) production. In some experiments,
PMN were stimulated through the incubation with 1 mg/
ml mAbs (anti-FcgR, anti-CR1 and/or anti-CR3) or 40/
160 mIU/ml LH, hCG or FSH. Hydrogen peroxide was
measured by Andreae’s scopoletin procedure (Andreae,
1995). Briefly, scopoletin was converted to non-fluor-
escent oxidized scopoletin by reacting it with hydrogen
peroxide and HPO. The fluorescence (excitation wave-
length, 350 nm; emission wavelength, 460 nm) was
monitored with a recording spectrofluoro-photometer
(model RF-1500, Shimadzu Co. Ltd., Kyoto, Japan).
During these determinations, we added sodium azide to
a final concentration of 1 mM to block the catalase and
myeloperoxidase of PMN (Root et al., 1975; Root and
Metcalf, 1977). We previously confirmed that 1 mM
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sodium azide did not inhibit HPO and SOD at all (Root
and Metcalf, 1977; Nauseef et al., 1983). For the
estimation of superoxide, final 50 mg/ml of SOD were
added to convert the superoxide to hydrogen peroxide.
Superoxide production was evaluated as the increase in
amount of hydrogen peroxide generated by SOD. NO
was measured by a luminol-dependent chemilumines-
cence procedure described elsewhere (Catz et al., 1995).
Briefly, 1/105 PMN were incubated at 37 8C in the
phenol red-free Hanks balanced salt solution supple-
mented with 20 mM HEPES buffer pH7.4, and luminol
solution were admixed at the final concentration of 5
mM. In some tubes, 100 mM carboxy-PTIO was pre-
supplemented to scavenge NO. To estimate the amounts
of NO, the total chemiluminescence values were sub-
tracted the values in the presence of carboxy-PTIO
(Wanikiat et al., 1997; Pryor and Squadrito, 1995).
Chemiluminescence emission was monitored with a
recording luminescence leader (Model BLR-201, Aloka
Co.Ltd., Tokyo, Japan).
2.6. RT-PCR and southern hybridization
Total RNA was extracted from PMN by guanidine
thiocyanate and b-mercaptoethanol (Sambrook et al.,
1989). A reverse transcription (RT) reaction was carried
out (50 8C 50 min), followed by a denaturation period
of 5 min at 85 8C. Thereafter, a polymerase chain
reaction (PCR) with 40 cycles (94 8C for 30 s, 55 8C for
30 s, and 68 8C for 1 min, with a final extension period
of 7 min at 68 8C) was performed. The sense primer
corresponded to nucleotides 170/190 (exon2) of the
LHR gene and the antisense primer, to nucleotides
1026-1045 (exon11) (nucleotides are numbered from the
initiation ATG). And then, a nested PCR with 30 cycles
(94 8C for 30 s, 55 8C for 30 s, and 68 8C for 1 min,
with a final extension period of 7 min at 68 8C) was
performed. The sense primer corresponded to nucleo-
tides 386/405 (exon5) and antisense primer, to nucleo-
tides 952-971 (exon11). As a positive control for RT and
PCR, ASY /Nogo-B gene (Li et al., 2001) and human
ovary cDNA were subjected, respectively. As negative
controls for RT, experiments were done without addi-
tion of the RNA fraction or the enzyme. After nested
PCR, amplification DNA fragments were electrophor-
esed in 2% agarose gel. After blotted on a nylon
membrane (Biodyne, Pall BioSupport, East Hills, NY),
southern hybridization was done by using an alkaline
phosphatase enzyme labeled oligonucleotide probe,
which corresponded to nucleotides 575-816 of LHR
cDNA, to confirm the specificity of these PCR products.
The amplified PCR products were confirmed their
sequence by a DNA sequencer (310 Genetic Analyzer,
Applied Biosystems Japan Co.Ltd., Tokyo, Japan).
2.7. Scatchard analysis of LH receptor to PMN
LH was labeled with iodine-125 by Chloramin T
procedure (Dohi and Nisonoff, 1979). Specific activity
of the labeled compound was 3.39/104 cpm/ng. PMN
were resuspended in HBSS supplemented with 1 mM
sodium azide, 1 mM EDTA and/or 10 mM KCN to
minimize destruction of activated PMN with LH. PMN
of 1/105 were mixed with various concentrations of
labeled LH, incubated for 30 min at 0 8C and washed
with phosphate buffered saline by centrifugation. Re-
sulting precipitates were counted with a g-counter
(ARC-380, Aloka Co. Ltd., Tokyo, Japan). To exclude
non-specific binding of labeled LH to the PMN, we
subtracted the values in the presence of about 1000-fold
excess of hCG from the binding values.
2.8. Statistical analyses
Data are presented as the mean9/S.E. The analyses
were performed with a statistical package (STAT FLEX
Ver.5.0). The normality of the distribution of the data
was evaluated by the Bartlett test. When the data are
normally distributed, the parametric one-way analysis of
variance (ANOVA), and when not normally distributed,
the non-parametric Kruskal/Wallis test, were utilized,
and followed a Scheffe’s multiple range test. PB/0.05
was considered significant.
3. Results
3.1. The content of superoxide, hydrogen peroxide and
nitric oxide of peripheral blood PMN at the peri-
ovulatory period
We examined superoxide and hydrogen peroxide
content of female peripheral blood resident PMN during
a menstrual cycle (Fig. 1). Ovulatory day was expected
as described in Section 2. Particularly high levels of the
sum amounts of superoxide and hydrogen peroxide were
detected at the peri-ovulatory period. As shown in Fig.
2, ROI was particularly detectable in high levels at the 3
days of the period and the difference of the value was
significant (PB/0.01). We also evaluated NO produc-
tion during the menstruation cycle. The result showed
the very high NO production only at the ovulatory day
and the difference of the values was significant (PB/
0.01) (Fig. 3). These results indicated that peripheral
PMN were in an activated state particularly at the peri-
ovulatory period.
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3.2. Peripheral blood leukocyte count
The significant differences in the number of peripheral
blood leukocytes were not seen in a menstrual cycle (Fig.
4).
3.3. In vitro response of superoxide and NO production of
PMN to LH
We attempted to activate PMN at the pre-ovulatory
period with the pituitary LH. The luminol-dependent
Fig. 1. Released amounts of ROI by peripheral blood PMN during a menstrual cycle (four cases, A to D). The arrow indicated the day when urinary
LH concentration was /40 IU/l. (m) indicated released amounts of ROI, and (k) showed basal body temperature.
Fig. 2. High levels of ROI content of PMN were especially detectable
at the 3 days of peri-ovulatory period. Ovulatory day was expected as
described in Section 2. The values are expressed as the mean9/S.E.
(n/10). **, Significantly higher (PB/0.01) than menstrual phase (/9
to /5 days), peri-ovulatory phase (/2 and/2 days) and luteal phase
(/8 to /12 days).
Fig. 3. A high level of NO content of PMN was detected only at the
ovulatory day. The values are expressed as the mean9/S.E. (n/7). **,
Significantly higher (PB/0.01) than menstrual phase (/10 to /7
days), peri-ovulatory phase (/2, /1, /1 and /2 days) and luteal
phase (/7 to /10 days).
F. Shirai et al. / Molecular and Cellular Endocrinology 196 (2002) 21/2824
chemiluminescence of the PMN products was evaluated
in the absence and presence of carboxy-PTIO, a NO
scavenger. The difference of these values is dependent on
the amounts of produced NO. As shown in Fig. 5,
content of the fraction in the presence of carboxy-PTIO
increased dose-dependently with LH in 10 min. How-
ever, neither hCG nor FSH at the similar dose increased
the superoxide content. Thus, the elevation appeared to
be restricted to LH. Furthermore, the levels brought by
40/80 mIU/ml of LH were similar to those by anti-
CD16 and anti-CD35, or anti-CD16 and anti-CD11b
monoclonal antibodies (1 mg/ml each). NO production
was not significantly increased in a LH-dose dependent
manner.
3.4. mRNA expression of receptors for LH (LHR) on
PMN
To assess LHR expression in PMN, RT-PCR and
hybridization analysis of LHR mRNA was performed
on peripheral PMN in pre-ovulatory and ovulatory
phase. The results indicated that the nested PCR
products in either phase of three cases amplified 586
bp band, which was the same as human ovary cDNA,
and no bands amplified in negative controls (Fig. 6).
Human ovary cDNA, but not PMN cDNA also
amplified 397 and 687 bp bands, which may corre-
sponded to spliced forms of the mRNA (Minegishi et
al., 1990). The RT-PCR products were confirmed their
DNA sequences.
3.5. Scatchard analysis for binding of LH to LHR
In order to determine the number of binding sites of
LH on PMN, Scatchard analysis was carried out with
the 125I-labeled LH. The experiments were done in lower
concentration of the labeled LH than 0.2 mg/ml due to
the higher concentration lysed PMN. When estimating
nonspecific binding of labeled LH, 1000-fold excess of
Fig. 4. Peripheral blood leukocyte count during a menstrual cycle.
Values of five individuals (kmIj') were shown.
Fig. 5. Response of resident PMN to LH, hCG or FSH. Menstrual phase PMN (6 days after menstruation started) were incubated in vitro with LH,
hCG, FSH (40/160 mIU/ml) or mAbs (1 mg/ml). The hatched bars showed NO production, and the closed bars showed ROI production.
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unlabeled hCG were previously incubated with the
PMN. hCG did not lyse PMN probably because of a
lack of activation of PMN (Fig. 5), but was reported to
have the same binding site as LH (Dufau, 1998). The
results indicated that average 17 000 binding sites of LH
were extrapolated to be expressed on one PMN (Fig. 7).
The association constant for the binding was estimated
as 4.88/109 per M.
4. Discussion
We have demonstrated that human peripheral blood
PMN, particularly at the peri-ovulatory period, con-
tained high levels of superoxide and NO, and that the
pituitary LH, enhanced the superoxide levels of PMN in
vitro. The superoxide production was triggered by LH,
but not by hCG or FSH. These results suggested that the
production of high levels of superoxide by PMN may
play an important role in ovulation. Tamate K et al.
showed histochemically SOD in granulosa, theca and
luteal cells in the human ovary (Tamate et al., 1995).
Superoxide and hydrogen peroxide appeared to mediate
luteolysis and ovulation. Although, it is unclear from
where these materials were produced (Wang et al.,
1993).
We also clarified the mRNA expression of receptors
for LH (LHR) on the PMN. To our knowledge, there
are no reports for the existence of LHR on PMN,
although LHR have been reported to be detected on
many organs and tissues, including ovary, testis, uterus,
placenta, salpinx, brain and lymphocytes (Dufau, 1998;
Lin et al., 1995). RT-PCR and nested PCR experiments
were carried out. A band of 586 bp, which hybridized to
LHR cDNA, was detected in the products of PMN,
indicating the expression of LHR mRNA on PMN (Fig.
6). However, human ovary cDNA amplified not only a
586 bp band, but also 397 and 687 bp bands. The latters
may correspond to spliced forms of the mRNA (Mine-
gishi et al., 1990; Reinholz et al., 2000).
We enumerated the number of binding sites of LH on
PMN by Scatchard plots. High dose of 125I-labeled LH
let PMN to be autolysed. As shown in Fig. 5, higher
doses of LH induced high levels of ROI. Thus we could
not get values in lower r/c points. However, four points
of Scatchard plots showed a straight line, the slope of
which indicated that the association constant Ka was
about 4.88/109 per M. The extrapolated value in X-
axis indicated about 17 000 LHR per cell (Fig. 7). These
values were close to the reported: that is, the Ka between
hCG and the rat ovarian receptors, 6.20/109 per M
(Roche and Ryan, 1989) and 20 000 LHR per cell on rat
Leydig cells (Dufau and Catt, 1978).
The binding of LH to LHR triggered ROI formation
in a short time (Fig. 5), suggesting the presence of
another pathway to activate NADPH oxidase, similarly
as the mechanism via FcR (Chanock et al., 1994; DeLeo
et al., 1999; Miller and Britigan, 1997; Segal and Jones,
1979). LH, but not by hCG or FSH activated PMN.
These three hormones are composed of two subunits, a
and b: the a-subunits are identical and the b-subunits
are different for the different hormones. It is the b-
Fig. 6. LHR mRNA expression in PMN or ovary. RNA was extracted
from PMN, electrophoresed, blotted, and hybridized with the labeled
LH cDNA probe. (a) Ovary mRNA, pre-ovulatory phase of PMN
(#1) and ovulatory phase of PMN (#2). Ovary cDNA was subjected as
a positive control. (b) Ovulatory phase of PMN (#3). Samples omitted
of the RNA (H2O) or the RT enzyme (RT-) were used as negative
controls.
Fig. 7. Scatchard analysis of LH receptors on PMN. PMN were
assayed for binding with increasing amounts of 125I-labeled LH and a
constant amount of unlabeled hCG in a total volume of 0.1 ml. Data
was plotted according to Scatchard, giving a Ka/4.88/109 per M. r
represents number of LH molecules bound to one cell, assuming that
the molecular weight of LH was 29 000. c represents molar concentra-
tion of LH. Each point is the average of triplicate determinations.
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subunit that determines the specific activity of each
hormone (Dufau, 1998; Lapthorn et al., 1994; Wu et al.,
1994). Our data showed that 40 mU/ml of LH resulted
in PMN activation, but 160 mU/ml of hCG and FSH
did not (Fig. 5). This may reflect the difference of b-
subunit of each hormone. But there is a report that hCG
administration induced ovulation in vivo (Andersen et
al., 1995; Testart and Frydman, 1982; Testart et al.,
1981). In their in vivo experiments, other signals may be
included.
There are many reports that NO played important
roles on ovulation (Faletti et al., 1999; Mitsube et al.,
1999). NO might maintain the state of ovarian vaso-
relaxation required to accommodate the ovulatory
increase in blood flow, blood volume and plasma
exudation (Bonello et al., 1996). Therefore, we examined
NO content of PMN during a menstrual cycle and NO
production by LH (Figs. 3 and 5). The unexpectedly
high level of NO content was detected on PMN
particularly on the ovulatory day. This result suggested
that PMN exposed to LH surge prior to ovulatory day
would induce iNOS, which could consequently catalyze
NO production. Our data is coincides with a recent
report by Mitsube K et al. , that showed the expression
of iNOS in the LH-primed ex-vivo perfused rat ovary by
immuno-blotting, though they did not show which kinds
of cells were expressed in the ovary (Mitsube et al.,
1999). NO production of PMN to increased concentra-
tion of LH was not observed. This suggests that these
cases of NO production might be catalyzed by a
constitutional enzyme eNOS (Forstermann et al.,
1998), because the induction of iNOS would take more
than 8 h (Stuehr and Marletta, 1987).
Products of inflammatory leukocytes had shown to
play a role in the process of follicle rupture (Brannstrom
and Janson, 1991). It was reported that on the in vitro-
perfused LH-primed rat ovary, but not on the non-
primed ovary, the addition of leukocytes markedly
potentiated the ovulation response (Hellberg et al.,
1991). It would be postulated that the perfused LH
bound to PMN within the ovary. As LH-bound PMN
resulted in production of superoxide and NO, these
PMN may greatly contribute to the process of follicle
rupture.
The regular bacterial infections accompany luekocy-
tosis, but a significant luekocytosis was not observed
during a menstrual cycle (Fig. 4). Furthermore, we did
not find significant difference in the levels of the ROI in
the presence of 500-fold excess of heat-killed Staphylo-
coccus aureus among a menstrual cycle (data not
shown). Considering the humoral and cytokine net-
works of ovulatory process, the temporal activation of
PMN at ovulatory period may be a physiologic event for
the induction of follicle rupture, rather than a defensive
one against infection.
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